Regenxbio (NASDAQ: RGNX) reported Q3 EPS of ($1.52), versus ($0.73) reported last year. Revenue for the quarter came in at $1.1 million, versus $500 thousand reported last year.

For earnings history and earnings-related data on Regenxbio (RGNX) click here.